One of My Top Small-Cap Biotech Picks Made a Move. Here’s How I Trade It
The FDA just granted this biopharma name a key designation. Let me show you in detail how I handle a stock like this.
A Small-Cap Stock Is Offering an Opportunity — And Almost Nobody Is Covering It
Amid ‘troubling’ market action Monday, here’s what to know about one of my top small-cap plays.